The therapeutic antitumor potency of a prime-boost vaccination strategy was explored, based on the mutated, nontransforming forms of the E6 (E6F47R) and E7 (E7GGG) oncogenes of Human Papilloma Virus type 16 (HPV16), fused to the Potato virus X (PVX) coat protein (CP) sequence. Previous data showed that CP fusion improves the immunogenicity of tumor-associated antigens and may thus increase their efficacy. After verifying the correct expression of E6F47RCP and E7GGGCP inserted into DNA and Fowlpox virus recombinants by Western blotting and immunofluorescence, their combined use was evaluated for therapy in a pre-clinical mouse model of HPV16-related tumorigenicity. Immunization protocols were applied using homologous (DNA/DNA) or heterologous (DNA/Fowlpox) prime-boost vaccine regimens. The humoral immune responses were determined by ELISA, and the therapeutic efficacy evaluated by the delay in tumor appearance and reduced tumor volume after inoculation of syngeneic TC-1* tumor cells. Homologous DNA/DNA genetic vaccines were able to better delay tumor appearance and inhibit tumor growth when DNAE6F47RCP and DNAE7GGGCP were administered in combination. However, the heterologous DNA/Fowlpox vaccination strategy was able to delay tumor appearance in a higher number of animals when E6F47RCP and in particular E7GGGCP were administered alone.
Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X / E. Illiano, M. Bissa, F. Paolini, C. Zanotto, C. De Giuli Morghen, R. Franconi, A. Radaelli, A. Venuti. - In: VIRUS RESEARCH. - ISSN 0168-1702. - 225(2016 Oct), pp. 82-90.
|Titolo:||Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X|
ILLIANO, ELENA (Primo)
BISSA, MASSIMILIANO (Secondo)
RADAELLI, ANTONIA (Penultimo)
|Parole Chiave:||E6 and E7 modified oncoproteins; Fowlpox virus recombinants; HPV therapeutic vaccines; potato virus X coat protein; prime/boost immunizations|
|Settore Scientifico Disciplinare:||Settore BIO/19 - Microbiologia Generale|
|Data di pubblicazione:||ott-2016|
|Data ahead of print / Data di stampa:||21-set-2016|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.virusres.2016.09.011|
|Appare nelle tipologie:||01 - Articolo su periodico|